SCHEMBL482437

SCHEMBL482437

c1ccc(-c2ccccc2Pc2ccc3ccccc3c2-c2c(Pc3ccccc3-c3ccccc3)ccc3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.40
TNF P01375 1/20 0.38
WDR5 P61964 1/20 0.37
ALDH1A1 P00352 5/20 0.37
TDP1 Q9NUW8 3/20 0.37
TSHR P16473 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP2A6 P11509 1/20 0.37
KDM4E B2RXH2 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
GPR84 Q9NQS5 2/20 0.36
MAPT P10636 7/20 0.36
HPGD P15428 3/20 0.36
MPI P34949 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TP53 P04637 1/20 0.35
NFKB1 P19838 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29585116 0.80 ALDH1A1 (0.44) DNMT1WDR5ALDH1A1TDP1TSHR
SCHEMBL1925928 0.80 ALDH1A1 (0.44) DNMT1WDR5ALDH1A1TDP1TSHR
SCHEMBL30810802 0.79 ALDH1A1 (0.46) ALDH1A1TDP1TSHRHSD17B10CYP2A6
SCHEMBL5531704 0.79 ALDH1A1 (0.46) ALDH1A1TDP1TSHRHSD17B10CYP2A6
SCHEMBL8614233 0.77 HSP90AA1 (0.39) ALDH1A1TDP1HSD17B10MEN1KMT2A
SCHEMBL28386630 0.77 ALDH1A1 (0.44) ALDH1A1TDP1TSHRHSD17B10CYP2A6
SCHEMBL1304679 0.77 ALDH1A1 (0.44) ALDH1A1TDP1TSHRHSD17B10CYP2A6
Hydrochloric Acid SCHEMBL28378153 0.77 ALDH1A1 (0.44) ALDH1A1TDP1HSD17B10CYP2A6HPGD
SCHEMBL2824075 0.76 HSD17B10 (0.44) DNMT1WDR5ALDH1A1TDP1TSHR
SCHEMBL29489771 0.76 HSD17B10 (0.44) DNMT1WDR5ALDH1A1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7183437-B2 Method for preparing three types of benzidine compounds in a specific ratio LABELTEK INC. (TW) 2007-02-27 US claimed
US-20050080292-A1 Method for preparing three types of benzidine compounds in a specific ratio LABELTEK INC. (TW) 2005-04-14 US claimed
US-20210318619-A1 COMPOSITION, METHOD OF PRODUCING SUBSTRATE, METHOD OF FORMING PATTERN, AND METHOD OF FORMING REVERSE PATTERN JSR CORPORATION (JP) 2021-10-14 US disclosed
US-8604030-B2 Fused piperidine compound and pharmaceutical containing same KOWA COMPANY, LTD. (JP) 2013-12-10 US disclosed
US-20120108581-A1 FUSED PIPERIDINE COMPOUND AND PHARMACEUTICAL CONTAINING SAME KOWA COMPANY, LTD (JP) 2012-05-03 US disclosed
EP-2412710-A1 FUSED PIPERIDINE COMPOUND AND PHARMACEUTICAL AGENT COMPRISING SAME Kowa Company, Ltd. (JP) 2012-02-01 EP disclosed
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-05-22 US disclosed
EP-1847535-A1 1-(PIPERIDIN-4-YL)-1H-INDOLE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-10-24 EP disclosed
US-7183437-B2 Method for preparing three types of benzidine compounds in a specific ratio LABELTEK INC. (TW) 2007-02-27 US disclosed
EP-1229065-B1 Process for the preparation of a polyesteramide COUNCIL SCIENT IND RES (IN) 2005-06-08 EP disclosed
US-20050080292-A1 Method for preparing three types of benzidine compounds in a specific ratio LABELTEK INC. (TW) 2005-04-14 US disclosed
EP-1229065-A1 Process for the preparation of a polyesteramide Council of Scientific and Industrial Research (IN) 2002-08-07 EP disclosed
US-6410681-B1 ALTERNATING POLYESTER, POLYAMIDE UNITS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives TPH1, HTR1D, HTR1B DNMT1 2081/4885TNF 4686/4885WDR5 492/4885
US-20050080292-A1 Method for preparing three types of benzidine compounds in a specific ratio DRD4, DRD5, DDT DNMT1 848/4885TNF 4053/4885WDR5 1788/4885
US-20120108581-A1 FUSED PIPERIDINE COMPOUND AND PHARMACEUTICAL CONTAINING SAME EPOR, JAK2, HBZ DNMT1 2572/4885TNF 1162/4885WDR5 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.